200 51960 advanced:3.55891312765391 cancer:3.0880202142233 case:0.325148690291958 cohort:2.32203570971108 control:0.919855798038651 design:2.29943659920322 draw:1.80971327284465 eric:4.53974238066564 figure:1.80971327284465 men:2.38025813131226 follow:2.04646830498498 men:2.38025813131226 gonna:3.55891312765391 health:2.6957904563707 questionnaire:2.27105883934727 50000:3.84659520010569 levels:1.07400647786591 lorelei:4.53974238066564 1986:2.72337710063538 mucci:4.25206030821386 nested:2.93030446823154 professionals:6.88226018399506 prostate:3.84659520010569 invited:2.74798291143758 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 started:0.748005541111992 study:2.07214292158254 talk:0.84683782344952 thought:1.92478260262944 undertook:4.53974238066564
51960 97430 grow:1.51122028428865 levels:3.24045939653538 source:3.55891312765391 cancer:1.54401010711165 taking:4.02891675689965 interesting:1.68711095075232 part:0.802072762382268 takes:1.94947521521981 biological:0.90215622093925 nail:3.15344801954575 reflect:0.60791674794131 including:1.44869992730732 thought:0.675510039073838 year:1.66806275578162 study:1.07400647786591 50000:2.72337710063538 study:8.50412061642772 beginning:1.0844777777332 happened:0.867670044868081 prostate:3.84659520010569 toenails:0.834333624600489 factors:1.49521994294221 toenails:2.54731221597543 toenail:3.69244452027843 men:0.748005541111992 started:0.888061252106805 nail:1.71846235244443 investigators:1.92478260262944 collect:12.0867502706989 study:1.4551892245079
97430 147090 ed:3.24045939653538 study:0.489454245962768 nested:0.325148690291958 1987:7.69319040021138 ed:1.68711095075232 case:0.919855798038651 study:9.8904149775476 professionals:1.02323415249249 1987:4.9452074887738 man:1.34789522818535 author:3.80672045060016 back:9.8904149775476 37000:2.74798291143758 population:2.93030446823154 source:0.514390689930487 health:3.44113009199753 referred:2.38025813131226 clark:1.17244655067916 larry:1.38985942728439 study:2.54731221597543 follow:1.77612250421361 toenails:8.0578335137993 study:1.54401010711165
147090 195230 study:7.11782625530782 follow:1.28164584264415 basically:3.0880202142233 nested:0.975446070875874 case:0.919855798038651 study:4.9452074887738 ed:0.802072762382268 1996:1.02323415249249 funds:3.84659520010569 levels:1.07400647786591 limited:1.66806275578162 measure:0.793215308548206 37000:1.36168855031769 undertook:2.93030446823154 prostate:1.57791165878733 cases:1.78820706762369 1994:7.69319040021138 advanced:0.614474148487469 cancer:0.668541369757745 undertook:1.44869992730732 selenium:7.69319040021138 prostate:0.37566448042886 stored:2.99929733971849 study:0.888061252106805 toenails:4.02891675689965 men:9.07948476133128 wanted:0.956223442209526
195230 241840 prostate:1.54401010711165 case:0.650297380583916 found:3.84659520010569 researchers:0.634408363388287 controls:2.75956739411595 risk:0.87618073453599 compare:2.41947884446554 specimen:0.778542264972074 health:1.02323415249249 epidemiological:1.76715365842585 37000:1.34789522818535 identified:1.83169217956343 study:4.9452074887738 1988:0.810040932031445 means:0.526366880977203 looked:4.08506565095307 control:5.86060893646308 number:0.153557735843091 men:3.44113009199753 developing:3.84659520010569 larry:1.17244655067916 remember:0.417998844255421 toenail:1.94947521521981 find:0.634408363388287 risk:1.84342244546241 set:0.668541369757745 time:1.44869992730732 set:0.75132896085772 study:3.69244452027843 study:1.18408166947574 cancer:0.0700101655726489 follow:4.02891675689965 clark:1.54401010711165
241840 274870 develop:3.55891312765391 controls:0.550758334101362 cancer:3.0880202142233 follow:0.325148690291958 cancer:0.919855798038651 men:0.87618073453599 years:2.04646830498498 risk:1.76715365842585 health:1.34789522818535 men:3.15344801954575 selenium:2.14801295573182 toenails:0.793215308548206 melanoma:4.53974238066564 33000:4.08506565095307 follow:0.153557735843091 calculate:0.984394319176222 population:0.514390689930487 professionals:3.44113009199753 advanced:3.84659520010569 odds:0.654748047625409 measure:2.34251780332942 relative:0.614474148487469 measured:7.69319040021138 skin:3.69244452027843 source:2.54731221597543 study:0.296020417368935 men:8.0578335137993 toenails:0.970126149671934
274870 320540 developing:3.55891312765391 question:3.24045939653538 prostate:1.54401010711165 nested:0.325148690291958 trial:1.14971829960161 study:2.32203570971108 cancer:0.634408363388287 authors:2.54731221597543 case:0.919855798038651 thinking:3.44113009199753 paper:2.11199414471758 risk:0.87618073453599 risk:0.748005541111992 lowest:1.07400647786591 estimate:0.984394319176222 60:1.47947158597407 men:3.44113009199753 33000:2.69391569016731 compared:1.36168855031769 conducted:2.93030446823154 read:1.7263316639056 advanced:3.84659520010569 talk:1.56108257075097 results:1.17244655067916 chance:1.52748080516043 levels:2.34251780332942 line:0.634408363388287 lower:1.22894829697494 critiquing:0.888061252106805 detail:0.42341891172476 questions:1.83169217956343 toenails:4.02891675689965 randomized:1.54401010711165
320540 367760 address:2.14184710786727 advanced:7.11782625530782 bit:0.550758334101362 cancer:4.63203032133495 case:0.650297380583916 complex:2.4603008389858 control:0.919855798038651 definition:1.68711095075232 design:1.14971829960161 diagnosed:5.00418826734486 discuss:1.9747930232041 identified:1.83169217956343 participant:3.84956520525888 population:0.514390689930487 principles:2.80514132527753 prostate:11.5397856003171 question:1.56108257075097 researchers:1.94947521521981 risk:1.84342244546241 sampling:2.00562410927323 set:0.75132896085772 source:2.54731221597543
367760 408430 case:0.325148690291958 simply:2.59383223161032 control:1.8397115960773 diagnosed:1.66806275578162 exclude:5.73153189418792 selenium:2.58909849496012 relates:0.396607654274103 number:0.153557735843091 exposure:4.9452074887738 participant:3.84956520525888 person:0.582108863985438 potential:2.95894317194814 question:1.56108257075097 question:1.28164584264415 risk:0.614474148487469 measurement:3.84659520010569 set:0.37566448042886 oftentimes:2.59383223161032 exposure:0.296020417368935 study:0.209009040379305
408430 451480 years:1.70652903660942 case:0.325148690291958 complicated:2.59383223161032 continuous:1.49521994294221 divided:0.725699783597694 equal:0.462204936759917 exposure:2.58909849496012 study:0.778542264972074 groups:0.249282939517245 happened:0.60791674794131 recently:1.94947521521981 influence:1.52748080516043 levels:1.07400647786591 potential:1.66806275578162 measure:0.793215308548206 oftentimes:4.9452074887738 findings:1.47947158597407 question:0.520360856916991 quintiles:4.53974238066564 reflect:3.07340531187221 reflect:2.99043988588442 selenium:7.69319040021138 study:0.59204083473787 window:2.38025813131226 20:0.485063074835967 yesno:4.25206030821386
451480 495230 bias:5.9243790696123 biases:2.64262239577975 clark:3.84659520010569 compare:0.634408363388287 concepts:1.92478260262944 concerned:2.08300660784433 contrast:3.3357695763397 core:4.25206030821386 epidemiology:1.43366204994278 estimate:0.748005541111992 exposure:2.58909849496012 finally:2.4390281230743 gonna:3.55891312765391 great:2.34251780332942 influence:3.89895043043962 larry:4.9452074887738 measurement:0.793215308548206 potential:1.47947158597407 published:2.38025813131226 question:1.04072171383398 randomized:1.17244655067916 relative:2.34251780332942 relate:2.5632916852883 risk:0.614474148487469 study:0.888061252106805 subsequent:3.07340531187221 undertaken:4.53974238066564
495230 538130 cancer:3.55891312765391 cancer:1.70652903660942 secondary:1.14971829960161 found:1.11656609228471 studies:3.55891312765391 selenium:1.40424816473649 risk:6.1760404284466 prostate:0.634408363388287 randomized:2.41947884446554 1996:3.5343073168517 national:3.3357695763397 blood:2.99929733971849 association:1.07400647786591 selenium:1.47947158597407 analysis:2.72337710063538 years:2.4603008389858 men:2.5028604534046 lower:11.5397856003171 men:2.34489310135832 60:1.84342244546241 found:4.02891675689965 undertook:1.44869992730732 randomized:11.5397856003171 placebo:0.888061252106805 biomarkers:4.02891675689965 study:1.54401010711165 study:4.53974238066564 cancer:4.53974238066564 prostate:0.485063074835967
538130 581540 agent:2.93030446823154 placebo:2.1689555554664 based:1.00362568110411 randomized:0.281768394661733 cancer:4.63203032133495 chemo:4.9452074887738 conducted:2.54731221597543 data:0.231182897873627 factorial:1.14971829960161 time:2.64262239577975 epidemiological:2.41947884446554 called:3.44113009199753 published:1.02323415249249 states:2.64262239577975 35000:1.36168855031769 vitamin:2.5028604534046 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:7.69319040021138 study:2.38025813131226 diagnosis:1.17244655067916 design:1.87715455364018 recruited:3.07340531187221 select:1.44869992730732 selenium:15.3863808004228 specifically:1.29454924748006 united:1.41884696415764 average:0.296020417368935 thinking:1.83169217956343 cancer:0.0700101655726489 trail:4.9452074887738 undertaken:4.53974238066564 men:1.70652903660942 selenium:5.99859467943698
581540 627220 question:2.02743675668952 association:1.11656609228471 cancer:3.0880202142233 clark:3.84659520010569 question:0.634408363388287 study:2.08300660784433 contrast:3.3357695763397 randomized:0.919855798038651 advantages:2.99929733971849 protective:0.96552583487184 epidemiological:4.83895768893108 found:1.87715455364018 plausible:2.38025813131226 found:3.5343073168517 cancer:2.64262239577975 larry:4.9452074887738 concerned:3.44113009199753 supplementation:2.59383223161032 prostate:7.69319040021138 evidence:3.07340531187221 guess:1.04072171383398 randomization:2.34489310135832 relative:2.34251780332942 results:0.634408363388287 risk:1.22894829697494 selenium:7.69319040021138 study:1.18408166947574 selenium:3.69244452027843 control:1.54401010711165 years:0.485063074835967
627220 654100 answers:0.538488241509547 bias:1.9747930232041 comments:2.86576594709396 comparison:1.9747930232041 confounding:1.36168855031769 controlled:0.919855798038651 critique:6.88226018399506 epidemiological:2.41947884446554 exposure:1.29454924748006 final:1.21951406153715 forward:2.30615015915854 interpretation:1.52748080516043 letting:3.24045939653538 logging:2.34251780332942 outcomes:0.654748047625409 part:1.0844777777332 post:2.86576594709396 providing:2.05483573087764 question:1.04072171383398 randomized:1.17244655067916 study:0.888061252106805 thoughts:1.92478260262944
